Is Ready‐To‐Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple‐Blinded Clinical Trial
Journal of Cosmetic Dermatology · 2026-04 · 25 (4)
DOI: 10.1111/jocd.70816 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 26.03.2026. Verfasst von Jacqueline Rosa Gonçalves und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dentistry, Ingá University Center, Uningá, Paraná, Brazil. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Skin Aging, Neuromuscular Agents, Cosmetic Techniques. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Background
Most commercially available botulinum toxin A (BoNT‐A) formulations are lyophilized or vacuum‐dried powders requiring reconstitution. Recently a ready‐to‐use formulation (RTUaboBoNT‐A) has been introduced. Although its efficacy in reducing glabellar lines has been reported, comparative data with powder onabotulinumtoxinA (OnaBoNT‐A) remain limited.
Aims
To evaluate the efficacy, durability, and safety of RTUaboBoNT‐A compared with OnaBoNT‐A for moderate to severe glabellar wrinkles: Methods Forty women (25–50 years) were randomly allocated to receive either OnaBoNT‐A ( n = 20) or RTUaboBoNT‐A ( n = 20) at equivalent doses in the procerus and corrugator muscles. Outcomes included Electromyography activity (EMG), Merz 5‐point glabellar lines scale, FACE‐Q satisfaction scores, perceived age and pain intensity (VAS). Assessments were performed at baseline and 1, 2‐, 3‐, 4‐ and 5‐months post‐injection. Statistical analysis included two‐way repeated‐measures ANOVA with Bonferroni's post hoc, chi‐squared tests and independent Student's t‐tests.
Results
No significant intergroup differences were observed in EMG activity of the assessed muscles across follow‐ups ( p > 0.05). Glabellar lines severity was comparable between groups at rest and maximum contraction throughout the study ( p > 0.05). Higher satisfaction scores were observed at 2‐months in the OnaBoNT‐A group ( p = 0.01). Pain during injection was greater with RTUaboBoNT‐A ( p = 0.02). No intergroup differences were found in perceived age ( p > 0.05).
Conclusion
The RTUaboBoNT‐A demonstrated similar efficacy, durability, and safety profile to OnaBoNT‐A for the treatment of glabellar lines. With minor differences in satisfaction and injection disconfort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dentistry, Ingá University Center, Uningá, Paraná, Brazil.
- Department of Dentistry, Federal University of Santa Catarina, Florianopolis, Brazil.
- Department of Dentistry, University of Ponta Grossa, Ponta Grossa, Paraná, Brazil.
- Department of Dentistry, Sao Leopoldo Mandic University, Campinas, Brazil.
- Egas Moniz Center for Interdisciplinary Research (CiiEM); Egas Moniz School of Health & Science, Caparica, Almada, Portugal.
- Division of Oral Diagnostics and Rehabilitation, Department of Dental Medicine, Karolinska, Huddinge, Sweden.
ORCID-Profile: Mariana Barbosa Câmara-Souza, Giancarlo De la Torre Canales
Förderung
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Gonçalves, J. R., Valesan, L. F., Shishido, A. C. L. N., Sanchez-Ayala, A., Carbone, A. C., Câmara-Souza, M. B., & De la Torre Canales, G. (2026). Is Ready‐To‐Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple‐Blinded Clinical Trial. Journal of Cosmetic Dermatology, 25(4). https://doi.org/10.1111/jocd.70816
Vancouver
Gonçalves JR, Valesan LF, Shishido ACLN, Sanchez-Ayala A, Carbone AC, Câmara-Souza MB, et al. Is Ready‐To‐Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple‐Blinded Clinical Trial. Journal of Cosmetic Dermatology. 2026;25(4). doi:10.1111/jocd.70816
BibTeX
@article{Gonalves2026,
author = {Gonçalves, Jacqueline Rosa and Valesan, Ligia Figueiredo and Shishido, Ana Claudia Laureano Navarro and Sanchez-Ayala, Alfonso and Carbone, Ana Claudia and Câmara-Souza, Mariana Barbosa and De la Torre Canales, Giancarlo},
title = {Is Ready‐To‐Use AbobotulinumtoxinA More Effective Than OnabotulinumtoxinA for Glabellar Lines? A Randomized, Controlled, Triple‐Blinded Clinical Trial},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {4},
doi = {10.1111/jocd.70816}
}
EUVIMED